357 related articles for article (PubMed ID: 28120141)
1. Autoimmune Movement Disorders: a Clinical and Laboratory Approach.
Honorat JA; McKeon A
Curr Neurol Neurosci Rep; 2017 Jan; 17(1):4. PubMed ID: 28120141
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune movement disorders.
Mckeon A; Vincent A
Handb Clin Neurol; 2016; 133():301-15. PubMed ID: 27112684
[TBL] [Abstract][Full Text] [Related]
3. Movement disorders in paraneoplastic and autoimmune disease.
Panzer J; Dalmau J
Curr Opin Neurol; 2011 Aug; 24(4):346-53. PubMed ID: 21577108
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune Movement Disorders.
Fearon C; O'Toole O
Semin Neurol; 2018 Jun; 38(3):316-329. PubMed ID: 30011412
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune and paraneoplastic movement disorders: An update.
Baizabal-Carvallo JF; Jankovic J
J Neurol Sci; 2018 Feb; 385():175-184. PubMed ID: 29406902
[TBL] [Abstract][Full Text] [Related]
6. Movement disorders of autoimmune origin.
Valldeoriola F
J Neurol; 1999 Jun; 246(6):423-31. PubMed ID: 10431765
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic movement disorders.
Popławska-Domaszewicz K; Florczak-Wyspiańska J; Kozubski W; Michalak S
Rev Neurosci; 2018 Sep; 29(7):745-755. PubMed ID: 29561731
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients.
Iorio R; Damato V; Evoli A; Gessi M; Gaudino S; Di Lazzaro V; Spagni G; Sluijs JA; Hol EM
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):138-146. PubMed ID: 28951498
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic movement disorders.
Grant R; Graus F
Mov Disord; 2009 Sep; 24(12):1715-24. PubMed ID: 19562765
[TBL] [Abstract][Full Text] [Related]
10. GAD65 neurological autoimmunity.
McKeon A; Tracy JA
Muscle Nerve; 2017 Jul; 56(1):15-27. PubMed ID: 28063151
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic autoimmune movement disorders.
Lim TT
Parkinsonism Relat Disord; 2017 Nov; 44():106-109. PubMed ID: 29097081
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody-associated movement disorders.
Mohammad SS; Ramanathan S; Brilot F; Dale RC
Neuropediatrics; 2013 Dec; 44(6):336-45. PubMed ID: 24203856
[TBL] [Abstract][Full Text] [Related]
13. Principles and approaches to the treatment of immune-mediated movement disorders.
Mohammad SS; Dale RC
Eur J Paediatr Neurol; 2018 Mar; 22(2):292-300. PubMed ID: 29289523
[TBL] [Abstract][Full Text] [Related]
14. Movement disorders in autoimmune encephalitis and paraneoplastic neurological syndromes.
Honnorat J; Joubert B
Rev Neurol (Paris); 2018 Nov; 174(9):597-607. PubMed ID: 30201423
[TBL] [Abstract][Full Text] [Related]
15. Movement disorders associated with neuronal antibodies.
Dash D; Pandey S
Acta Neurol Scand; 2019 Feb; 139(2):106-117. PubMed ID: 30338517
[TBL] [Abstract][Full Text] [Related]
16. N-methyl-D-aspartate receptor antibody-associated movement disorder without encephalopathy.
Hacohen Y; Dlamini N; Hedderly T; Hughes E; Woods M; Vincent A; Lim M
Dev Med Child Neurol; 2014 Feb; 56(2):190-3. PubMed ID: 24127856
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis.
Rosenfeld MR; Dalmau JO
Continuum (Minneap Minn); 2012 Apr; 18(2):366-83. PubMed ID: 22810133
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic movement disorders.
Mehta SH; Morgan JC; Sethi KD
Curr Neurol Neurosci Rep; 2009 Jul; 9(4):285-91. PubMed ID: 19515280
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune movement disorders with neuronal antibodies - an update.
Balint B; Bhatia KP
Curr Opin Neurol; 2021 Aug; 34(4):565-571. PubMed ID: 34010219
[TBL] [Abstract][Full Text] [Related]
20. The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders.
Damato V; Balint B; Kienzler AK; Irani SR
Mov Disord; 2018 Sep; 33(9):1376-1389. PubMed ID: 30218501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
